Capstone Investment Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$779K Buy
6,516
+3,038
+87% +$398K ﹤0.01% 952
2025
Q4
$474K Buy
3,478
+603
+21% +$86.7K ﹤0.01% 1165
2025
Q3
$424K Sell
2,875
-2,451
-46% -$340K ﹤0.01% 1487
2025
Q2
$689K Buy
+5,326
New +$645K ﹤0.01% 995
2025
Q1
Sell
-10,620
Closed -$1.32M 1939
2024
Q4
$1.23M Buy
10,620
+4,129
+64% +$522K ﹤0.01% 992
2024
Q3
$876K Sell
6,491
-1,414
-18% -$189K ﹤0.01% 1000
2024
Q2
$1.07M Buy
7,905
+3,614
+84% +$492K ﹤0.01% 960
2024
Q1
$555K Buy
+4,291
New +$518K ﹤0.01% 1494
2022
Q2
Sell
-1
Closed 2157
2022
Q1
$0 Sell
1
-3,012
-100% -$289K ﹤0.01% 2178
2021
Q4
$361K Sell
3,013
-9,369
-76% -$1.16M ﹤0.01% 1512
2021
Q3
$1.53M Buy
+12,382
New +$1.59M ﹤0.01% 1287
2020
Q1
Sell
-309
Closed -$24K 1405
2019
Q4
$24K Buy
+309
New +$24.1K ﹤0.01% 1350
2016
Q2
Sell
-82,700
Closed -$3.38M 867
2016
Q1
$3.38M Buy
+82,700
New +$3.05M 0.1% 134

Other funds holding XYL

Capstone Investment Advisors's XYL Position: Q1 2026 in Review

Capstone Investment Advisors increased its Xylem (XYL) stake by 87% in Q1 2026, buying an estimated $398K and bringing the position to 6,516 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

Capstone Investment Advisors first reported a position in XYL in Q1 2016 and has held it in 13 quarters since. The position peaked at $3.38M in Q1 2016. 1,110 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Capstone Investment Advisors held 6,516 shares of Xylem worth $779K as of Q1 2026.
  • Capstone Investment Advisors bought 3,038 Xylem shares in Q1 2026, an estimated $398K.
  • Xylem made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #952 holding.
  • Capstone Investment Advisors first reported a position in Xylem in Q1 2016 and has held it in 13 quarters since.
  • Capstone Investment Advisors's Xylem position peaked at $3.38M in Q1 2016.
  • 1,110 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.